IIT PH1 KDS-1001 in Patients With CML
Condition(s):CML (Chronic Myelogenous LeukemiaLast Updated:July 29, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):CML (Chronic Myelogenous LeukemiaLast Updated:July 29, 2022Not yet recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:February 8, 2024Available
Condition(s):Chronic Phase Chronic Myelogenous Leukemia; Philadelphia Chromosome Positive; BCR-ABL1 Positive Chronic Myelogenous Leukemia; BCR-ABL1 PositiveLast Updated:October 27, 2023Recruiting
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 PositiveLast Updated:March 5, 2024Recruiting
Condition(s):Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission; Chronic Myeloid Leukemia in RemissionLast Updated:December 13, 2023Recruiting
Condition(s):Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Minimal Residual DiseaseLast Updated:November 28, 2023Recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 6, 2024Recruiting
Condition(s):Chronic Myeloid Leukemia; Chronic Myeloid Leukemia, BCR/ABL-Positive; Chronic Myeloid Leukemia in RemissionLast Updated:October 23, 2023Recruiting
Condition(s):CML, Chronic Phase; TKILast Updated:November 3, 2023Recruiting
Condition(s):CML, Chronic PhaseLast Updated:April 29, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.